160
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Evolving horizons in renal angiomyolipoma: two decades of management strategies and clinical perspectives in a single institutional studyFootnote

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Article: 2346308 | Received 18 Jan 2024, Accepted 17 Apr 2024, Published online: 06 May 2024

References

  • Kapoor A, Girard L, Lattouf JB, et al. Evolving strategies in the treatment of tuberous sclerosis complex-associated angiomyolipomas (TSC-AML). Urology. 2016;89:19–26. Mar doi: 10.1016/j.urology.2015.12.009.
  • Kim JW, Kim JY, Ahn ST, et al. Spontaneous perirenal hemorrhage (wunderlich syndrome): an analysis of 28 cases. Am J Emerg Med. 2019;37(1):45–47. doi: 10.1016/j.ajem.2018.04.045.
  • Nason GJ, Morris J, Bhatt JR, et al. Natural history of renal angiomyolipoma favors surveillance as an initial approach. Eur Urol Focus. 2021;7(3):582–588. doi: 10.1016/j.euf.2020.06.004.
  • Mues AC, Palacios JM, Haramis G, et al. Contemporary experience in the management of angiomyolipoma. J Endourol. 2010;24(11):1883–1886. doi: 10.1089/end.2010.0223.
  • Ouzaid I, Autorino R, Fatica R, et al. Active surveillance for renal angiomyolipoma: outcomes and factors predictive of delayed intervention. BJU Int. 2014;114(3):412–417. doi: 10.1111/bju.12604.
  • Ljungberg B, Albiges L, Abu-Ghanem Y, et al. European association of urology guidelines on renal cell carcinoma: the 2019 update. Eur Urol. 2019;75(5):799–810. doi: 10.1016/j.eururo.2019.02.011.
  • Oesterling JE, Fishman EK, Goldman SM, et al. The management of renal angiomyolipoma. J Urol. 1986;135(6):1121–1124. Jun doi: 10.1016/s0022-5347(17)46013-7.
  • Chan KE, Chedgy E, Bent CL, et al. Surveillance imaging for sporadic renal angiomyolipoma less than 40 mm: lessons learnt and recommendations from the experience of a large district general hospital. Ann R Coll Surg Engl. 2018;100(6):480–484. doi: 10.1308/rcsann.2018.0040.
  • Maclean DF, Sultana R, Radwan R, et al. Is the follow-up of small renal angiomyolipomas a necessary precaution? Clin Radiol. 2014;69(8):822–826. doi: 10.1016/j.crad.2014.03.016.
  • Bhatt JR, Richard PO, Kim NS, et al. Natural history of renal angiomyolipoma (AML): most patients with large AMLs >4cm can be offered active surveillance as an initial management strategy. Eur Urol. 2016;70(1):85–90. doi: 10.1016/j.eururo.2016.01.048.
  • Swärd J, Henrikson O, Lyrdal D, et al. Renal angiomyolipoma-patient characteristics and treatment with focus on active surveillance. Scand J Urol. 2020;54(2):141–146. doi: 10.1080/21681805.2020.1716066.
  • Fernández-Pello S, Hora M, Kuusk T, et al. Management of sporadic renal angiomyolipomas: a systematic review of available evidence to guide recommendations from the european association of urology renal cell carcinoma guidelines panel. Eur Urol Oncol. 2020;3(1):57–72. doi: 10.1016/j.euo.2019.04.005.
  • Nelson CP, Sanda MG. Contemporary diagnosis and management of renal angiomyolipoma. J Urol. 2002;168(4 Pt 1):1315–1325. doi: 10.1016/S0022-5347(05)64440-0.
  • Dickinson M, Ruckle H, Beaghler M, et al. Renal angiomyolipoma: optimal treatment based on size and symptoms. Clin Nephrol. 1998;49(5):281–286.
  • De Luca S, Terrone C, Rossetti SR. Management of renal angiomyolipoma: a report of 53 cases. BJU Int. 1999;83(3):215–218. doi: 10.1046/j.1464-410x.1999.00932.x.
  • Simone G, Capitanio U, Tuderti G, et al. On-clamp versus off-clamp partial nephrectomy: propensity score-matched comparison of long-term functional outcomes. Int J Urol. 2019;26(10):985–991. doi: 10.1111/iju.14079.
  • Tuderti G, Brassetti A, Mastroianni R, et al. Expanding the limits of nephron-sparing surgery: surgical technique and mid-term outcomes of purely off-clamp robotic partial nephrectomy for totally endophytic renal tumors. Int J Urol. 2022;29(4):282–288. doi: 10.1111/iju.14763.
  • Bertolo R, Simone G, Garisto J, et al. Off-clamp vs on-clamp robotic partial nephrectomy: perioperative, functional and oncological outcomes from a propensity-score matching between two high-volume centers. Eur J Surg Oncol. 2019;45(7):1232–1237. doi: 10.1016/j.ejso.2018.12.005.
  • Sooriakumaran P, Gibbs P, Coughlin G, et al. Angiomyolipomata: challenges, solutions, and future prospects based on over 100 cases treated. BJU Int. 2010;105(1):101–106. doi: 10.1111/j.1464-410X.2009.08649.x.
  • Lin L, Wang C, Pei R, et al. Prophylactic selective arterial embolization for renal angiomyolipomas: efficacy and evaluation of predictive factors of significant shrinkage. Int Urol Nephrol. 2018;50(10):1765–1770. doi: 10.1007/s11255-018-1953-3.
  • Ramon J, Rimon U, Garniek A, et al. Renal angiomyolipoma: long-term results following selective arterial embolization. Eur Urol. 2009;55(5):1155–1161. doi: 10.1016/j.eururo.2008.04.025.